ADVB Advanced Biomed Inc. - Common Stock
$8,45
Kurs · Aug 19, 2026
Fundamentaldaten per Mai 15, 2026
52W-Spanne
$0–$24
34% of range
Analystenbewertung
—
Kursziel
—
P/E (TTM)
-2.6
ROE
-159.1%
Nettogewinnmarge
—
ADVB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$8.45
Marktkapitalisierung
$9M
P/E (TTM)
-2.6
EPS (TTM)
$-0.16
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-159.1%
Verschuldungsgrad
—
52W-Spanne
$0 – $24
ADVB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-0.16
2024-06-30
→
2025-06-30
Freier Cashflow
$-6M
2025-06-30
→
2025-06-30
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ADVB
Peer-Median
P/E (TTM)
-2.6
15.4
P/B (K/B)
2.6
1.6
Price / FCF (Kurs / FCF)
-1.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ADVB
Peer-Median
ROA
-59.4%
-54.9%
ROE
-159.1%
-98.0%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ADVB
Peer-Median
Current Ratio (Liquiditätsgrad)
2.1
4.7
Quick Ratio
1.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ADVB
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ADVB
Peer-Median
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ADVB | $15M | -4.4 | — | — | -159.1% | — |
| NSPR | $77M | -2.3 | 28.1% | -543.3% | -129.3% | 29.5% |
| RMTI | $33M | -5.5 | -31.8% | -7.7% | -15.8% | 16.9% |
| TELA | $53M | -1.4 | 15.8% | -48.4% | -501.1% | 67.7% |
| AIDX | — | — | 16.7% | -182.8% | -503.1% | 29.6% |
| NXGL | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $909.8K | · | |
| SG&A Expense | $2M | · | |
| Operating Expenses | $3M | · | |
| Interest Income | $24.9K | · | |
| Other Non-op | $-262.8K | · | |
| Pretax Income | $-3M | · | |
| Net Income | $-3M | · | |
| EPS (Basic) | $-0.16 | · | |
| EPS (Diluted) | $-0.16 | · | |
| Shares (Basic) | 20,525,699 | · | |
| Shares (Diluted) | 20,525,699 | · |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $3M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $13M | · | |
| PP&E (Net) | $125.2K | · | |
| PP&E (Gross) | $1M | · | |
| Accum. Depreciation | $1M | · | |
| Other Non-current Assets | $2.6K | · | |
| Total Assets | $14M | · | |
| Accounts Payable | $358.2K | · | |
| Accrued Liabilities | $575.8K | · | |
| Current Liabilities | $10M | · | |
| Capital Leases | $5.9K | · | |
| Total Liabilities | $10M | · | |
| Common Stock | $1.1K | · | |
| Retained Earnings | $-19M | · | |
| AOCI | $1M | · | |
| Stockholders' Equity | $3M | $619.0K | |
| Liabilities + Equity | $14M | · | |
| Shares Outstanding | 1,082,000 | 20,000,000 |
Cashflow 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $343.8K | · | |
| Operating Cash Flow | $-6M | · | |
| CapEx | $31.6K | · | |
| Investing Cash Flow | $-31.6K | · | |
| Financing Cash Flow | $6M | · | |
| Net Change in Cash | $295.9K | · | |
| Free Cash Flow | $-6M | · |
Rentabilität 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -59.4% | · | |
| ROE | -159.1% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.1 | · | |
| Quick Ratio | 1.0 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-3M | $-2M | |
| Market Cap | $15M | · | |
| P/E | -4.4 | · | |
| P/B | 4.4 | · | |
| P / Tangible Book | 4.4 | · | |
| P / Cash Flow | -2.6 | · | |
| P / FCF | -2.6 | · | |
| Earnings Yield | -22.9% | · |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $243.2K | $186.3K | $236.0K | $265.2K | $220.0K | $212.4K | $181.7K | $209.1K | $313.5K | |
| SG&A Expense | $276.6K | $210.3K | $287.9K | $1M | $347.5K | $67.7K | $338.3K | $495.5K | $431.9K | |
| Operating Expenses | $519.8K | $396.6K | $523.9K | $1M | $567.5K | $280.1K | $520.0K | $704.6K | $745.4K | |
| Interest Income | · | $9.2K | $448 | $9.5K | · | $15.4K | $10 | $33.4K | $104 | |
| Other Non-op | $31.0K | $42.9K | $136.6K | $418.7K | $-630.0K | $-314.8K | $254.4K | $-138.2K | $-310.9K | |
| Pretax Income | $-488.9K | $7M | $-386.9K | $-1M | $-1M | $-579.5K | $-265.6K | $-809.4K | $-1M | |
| Net Income | $-488.9K | $7M | $-386.9K | $-701.6K | $-1M | $-907.9K | $-265.6K | $-809.4K | $-1M | |
| EPS (Basic) | $-0.38 | $0.31 | $-0.02 | $-0.03 | $-1.35 | $-0.05 | $-0.01 | $-0.04 | $-0.05 | |
| EPS (Diluted) | $-0.38 | $0.31 | $-0.02 | $-0.03 | $-1.35 | $-0.05 | $-0.01 | $-0.04 | $-0.05 | |
| Shares (Basic) | 1,284,923 | 21,640,000 | 21,640,000 | -39,953,402 | 1,023,955 | 20,000,000 | 20,000,000 | 0 | 20,000,000 | |
| Shares (Diluted) | 1,284,923 | 21,640,000 | 21,640,000 | -39,953,402 | 1,023,955 | 20,000,000 | 20,000,000 | 0 | 20,000,000 |
Bilanz 20
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $3M | $3M | $3M | $5M | $3M | · | $3M | · | |
| Prepaid Expense | $8M | $8M | $3M | $3M | $3M | $481.7K | · | $443.1K | · | |
| Current Assets | $11M | $11M | $6M | $6M | $8M | $3M | · | $3M | · | |
| PP&E (Net) | $87.3K | $97.1K | $281.3K | $331.3K | $355.3K | $401.0K | · | $524.5K | · | |
| PP&E (Gross) | $1M | $1M | $2M | $2M | $2M | $2M | · | $2M | · | |
| Accum. Depreciation | $961.8K | $973.4K | $2M | $2M | $1M | $1M | · | $1M | · | |
| Intangibles | · | · | · | · | $20.3K | $50.5K | · | $119.0K | · | |
| Other Non-current Assets | $2.2K | $956 | $74.8K | $83.0K | · | · | · | · | · | |
| Total Assets | $11M | $11M | $6M | $7M | $8M | $5M | · | $4M | · | |
| Accounts Payable | $377.3K | $369.3K | $641.6K | $632.7K | $618.5K | $617.9K | · | $620.5K | · | |
| Accrued Liabilities | $238.5K | $224.0K | · | · | · | · | · | · | · | |
| Current Liabilities | $1M | $1M | $3M | $3M | $4M | $4M | · | $3M | · | |
| Capital Leases | $10.9K | $1.4K | $2.9K | $5.9K | $44.5K | $56.3K | · | $64.5K | · | |
| Total Liabilities | $1M | $1M | $3M | $3M | $4M | $4M | · | $3M | · | |
| Common Stock | $1.4K | $21.6K | $21.6K | $21.6K | $21.6K | $20.0K | · | $20.0K | · | |
| Retained Earnings | $-13M | $-13M | $-20M | $-19M | $-19M | $-17M | · | $-16M | · | |
| AOCI | $843.8K | $874.7K | $1M | $1M | $1M | $1M | · | $1M | · | |
| Stockholders' Equity | $9M | $9M | $3M | $3M | $4M | $619.0K | · | $2M | · | |
| Liabilities + Equity | $11M | $11M | $6M | $7M | $8M | $5M | · | $4M | · | |
| Shares Outstanding | 1,382,133 | 21,640,000 | 21,640,000 | 21,640,000 | 21,640,000 | 20,000,000 | · | 20,000,000 | · |
Cashflow 8
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9.3K | $-12.9K | $48.0K | $64.4K | $78.1K | $-56.8K | $102.2K | $153.9K | $83.0K | |
| Amort. of Intangibles | · | · | · | · | $30.2K | $33.6K | · | · | $31.9K | |
| Operating Cash Flow | $-239.8K | $-513.6K | $-610.3K | $-2M | $-3M | $-841.8K | $-29.7K | $-475.8K | $-1M | |
| CapEx | $1.3K | $12.9K | $1.8K | $20.1K | $2.2K | $-10.7K | $20.0K | $53.3K | $-26.7K | |
| Investing Cash Flow | $-1.3K | $-12.9K | $-1.8K | $-20.1K | $-2.2K | $10.7K | $-20.0K | $-53.3K | $26.7K | |
| Financing Cash Flow | $268.3K | $315.5K | $447.5K | $-765.5K | $6M | $408.3K | $392.5K | $323.5K | $562.2K | |
| Net Change in Cash | $-2.0K | $-45.9K | $-247.4K | $-2M | $3M | $10.2K | $39.0K | $-55.7K | $-112.9K | |
| Free Cash Flow | · | · | $-612.1K | · | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -5.2% | 89.3% | -12.4% | · | -33.4% | · | · | · | · | |
| ROE | -7.3% | 135.8% | -25.8% | · | -67.0% | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | 8.6 | 1.9 | · | 1.9 | · | · | · | · | |
| Quick Ratio | · | 2.1 | 0.9 | · | 1.3 | · | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $5M | $4M | $-3M | · | $-4M | · | · | · | · | |
| Market Cap | $6M | $6M | $10M | · | $85M | · | · | · | · | |
| P/E | -3.2 | 1.7 | -3.0 | · | -21.8 | · | · | · | · | |
| P/B | 0.7 | 0.7 | 3.2 | · | 20.5 | · | · | · | · | |
| P / Tangible Book | 0.7 | 0.7 | 3.2 | · | 20.6 | · | · | · | · | |
| P / Cash Flow | · | · | -15.9 | · | · | · | · | · | · | |
| P / FCF | · | · | -15.8 | · | · | · | · | · | · | |
| Earnings Yield | -31.6% | 58.2% | -33.5% | · | -4.6% | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-06-30 | 2024-06-30 | |
|---|---|---|
| Nettoergebnis | $-3M | $-3M |
| Verwässerte EPS | $-0.16 | $-0.14 |
Bilanz
| 2025-06-30 | 2024-06-30 | |
|---|---|---|
| Liquiditätsgrad | 2.1 | — |
| Quick Ratio | 1.0 | — |
Cashflow
| 2025-06-30 | 2024-06-30 | |
|---|---|---|
| Freier Cashflow | $-6M | — |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F)
Institutionelle Aktivität — Q4 2025 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 0 (-2 vs. Vorquartal) | 2 (+1 vs. Vorquartal) | 1 (-1 vs. Vorquartal) | 2 (+1 vs. Vorquartal) | -218K |
Verglichen mit Q3 2025. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.